4//SEC Filing
AUXILIUM PHARMACEUTICALS INC 4
Accession 0001193805-15-000077
CIK 0001182129operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:02 PM ET
Size
38.4 KB
Accession
0001193805-15-000077
Insider Transaction Report
Form 4
DEERFIELD PARTNERS, LP
10% OwnerOther
Transactions
- Disposition from Tender
Common Stock
2015-01-29−2,797,408→ 0 total(indirect: Through Deerfield Partners, L.P.) - Disposition from Tender
Common Stock
2015-01-29−3,469,974→ 0 total(indirect: Through Deerfield International Master Fund, L.P.)
Deerfield International Master Fund, L.P.
10% OwnerOther
Transactions
- Disposition from Tender
Common Stock
2015-01-29−2,797,408→ 0 total(indirect: Through Deerfield Partners, L.P.) - Disposition from Tender
Common Stock
2015-01-29−3,469,974→ 0 total(indirect: Through Deerfield International Master Fund, L.P.)
Flynn James E
10% OwnerOther
Transactions
- Disposition from Tender
Common Stock
2015-01-29−3,469,974→ 0 total(indirect: Through Deerfield International Master Fund, L.P.) - Disposition from Tender
Common Stock
2015-01-29−2,797,408→ 0 total(indirect: Through Deerfield Partners, L.P.)
DEERFIELD CAPITAL LP
10% OwnerOther
Transactions
- Disposition from Tender
Common Stock
2015-01-29−2,797,408→ 0 total(indirect: Through Deerfield Partners, L.P.) - Disposition from Tender
Common Stock
2015-01-29−3,469,974→ 0 total(indirect: Through Deerfield International Master Fund, L.P.)
DEERFIELD MANAGEMENT CO /NY
10% OwnerOther
Transactions
- Disposition from Tender
Common Stock
2015-01-29−3,469,974→ 0 total(indirect: Through Deerfield International Master Fund, L.P.) - Disposition from Tender
Common Stock
2015-01-29−2,797,408→ 0 total(indirect: Through Deerfield Partners, L.P.)
Footnotes (3)
- [F1]In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc. ("Auxilium"), Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these shares were exchanged for consideration comprised of a mix of cash and shares of Endo International plc in accordance with the Merger Agreement at the rate of $9.75 in cash and 0.3448 Endo shares per share of Auxilium common stock.
- [F2]This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. and Deerfield International Master Fund, L.P. (collectively, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.
- [F3]In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
AUXILIUM PHARMACEUTICALS INC
CIK 0001182129
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001182129
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:02 PM ET
- Size
- 38.4 KB